Effects of Oplopanax horridus on human colorectal cancer cells

Anticancer Research

Volumn 30, Issue 2, 2010, Pages 295-302

  Li, Xiao Li ^a,b   Sun, Shi ^a,b   Du, Guang Jian ^a,b   Qi, Lian Wen ^a,b   Williams, Stainley ^a   Wang, Chong Zhi ^a,b   Yuan, Chun Su ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Anti proliferation; Apoptosis; Cell cycle; Cyclin A; Cyclin B1; Human colorectal cancer; Oplopanax horridus

Indexed keywords

3 (4,5 DIMETHYLTHIAZOL 2 YL) 5 (3 CARBOXYMETHOXYPHENYL) 2 (4 SULFOPHENYL) 2H TETRAZOLIUM; ANTINEOPLASTIC AGENT; CYCLIN A; CYCLIN B1; LIPOCORTIN 5; OPLOPANAX HORRIDUS EXTRACT; PLANT EXTRACT; TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL STRAIN HCT116; CELL STRAIN HT29; CELL STRAIN SW 480; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; OPLOPANAX; OPLOPANAX HORRIDUS; PRIORITY JOURNAL;

APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; OPLOPANAX; PHYTOTHERAPY; PLANT EXTRACTS; TUMOR CELLS, CULTURED;

EID: 77950522150     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Joseph DA, Rim SH and Seeff LC: Use of colorectal cancer tests - United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep 57: 253-258, 2008.
2. Rychahou PG, Kang J, Gulhati P, Doan HQ, Chen LA, Xiao SY, Chung DH and Evers BM: Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis. Proc Natl Acad Sci USA 105: 20315-20320, 2008.
3. Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB and Maisonneuve P: Smoking and colorectal cancer: A meta-analysis. JAMA 300: 2765-2778, 2008.
4. Delval L and Klastersky J: Optic neuropathy in cancer patients. Report of a case possibly related to 5 fluorouracil toxicity and review of the literature. J Neurooncol 60: 165-169, 2002.
5. Henriette Tanja L, Guchelaar HJ and Gelderblom H: Pharmacogenetics in chemotherapy of colorectal cancer. Best Pract Res Clin Gastroenterol 23: 257-273, 2009.
6. Viale PH and Yamamoto DS: Cardiovascular toxicity associated with cancer treatment. Clin J Oncol Nurs 12: 627-638, 2008.
7. Chau I and Cunningham D: Treatment in advanced colorectal cancer: what, when and how? Br J Cancer 100: 1704-1719, 2009.
8. Jackson LN, Zhou Y, Qiu S, Wang Q and Evers BM: Alternative medicine products as a novel treatment strategy for inflammatory bowel disease. Am J Chin Med 36: 953-965, 2008.
9. Efferth T, Fu YJ, Zu YG, Schwarz G, Konkimalla VS and Wink M: Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicine. Curr Med Chem 14: 2024-2032, 2007.
10. Lee HJ, Lee EO, Lee JH, Lee KS, Kim KH, Kim SH and Lu J: In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin. Am J Chin Med 37: 127-142, 2009.
11. Wang CZ and Yuan CS: Potential role of ginseng in the treatment of colorectal cancer. Am J Chin Med 36: 1019-1028, 2008.
12. Wang CZ, Zhang B, Song WX, Wang A, Ni M, Luo X, Aung HH, Xie JT, Tong R, He TC and Yuan CS: Steamed American ginseng berry: ginsenoside analyses and anticancer activities. J Agric Food Chem 54: 9936-9942, 2006.
13. Fishbein AB, Wang CZ, Li XL, Mehendale SR, Sun S, Aung HH and Yuan CS: Asian ginseng enhances the anti-proliferative effect of 5-fluorouracil on human colorectal cancer: comparison between white and red ginseng. Arch Pharm Res 32: 505-513, 2009.
14. Li XL, Wang CZ, Mehendale SR, Sun S, Wang Q and Yuan CS: Panaxadiol, a purified ginseng component, enhances the anticancer effects of 5-fluorouracil in human colorectal cancer cells. Cancer Chemother Pharmacol, 2009.
15. Luo X, Wang CZ, Chen J, Song WX, Luo J, Tang N, He BC, Kang Q, Wang Y, Du W, He TC and Yuan CS: Characterization of gene expression regulated by American ginseng and ginsenoside Rg3 in human colorectal cancer cells. Int J Oncol 32: 975-983, 2008.
16. Wang CZ, Li XL, Wang QF, Mehendale SR, Fishbein AB, Han AH, Sun S and Yuan CS: The mitochondrial pathway is involved in American ginseng-induced apoptosis of SW-480 colon cancer cells. Oncol Rep 21: 577-584, 2009.
17. Kobaisy M, Abramowski Z, Lermer L, Saxena G, Hancock RE, Towers GH, Doxsee D and Stokes RW: Antimycobacterial polyynes of Devil's Club (Oplopanax horridus), a North American native medicinal plant. J Nat Prod 60: 1210-1213, 1997.
18. Tai J, Cheung S, Cheah S, Chan E and Hasman D: In vitro anti-proliferative and antioxidant studies on Devil's Club Oplopanax horridus. J Ethnopharmacol 108: 228-235, 2006.
19. Bloxton J, DerMarderosian A and Gibbs R: Bioactive constituents of Alaskan devil's root (Oplopanax horridus, Araliaceae). Econ Bot 56: 285-287, 2002.
20. Smith GW: Arctic pharmacognosia II. Devil's Club, Oplopanax horridus. J Ethnopharmacol 7: 313-320, 1983.
21. Wattenberg LW: Inhibition of azoxymethane-induced neoplasia of the large bowel by 3-hydroxy-3,7,11-trimethyl-1,6,10-dodecatriene (nerolidol). Carcinogenesis 12: 151-152, 1991.
22. Tai J, Cheung S, Chan E and Hasman D: Inhibition of human ovarian cancer cell lines by Devil's club Oplopanax horridus. J Ethnopharmacol, 2009.
23. Wang CZ, Xie JT, Fishbein A, Aung HH, He H, Mehendale SR, He TC, Du W and Yuan CS: Antiproliferative effects of different plant parts of Panax notoginseng on SW480 human colorectal cancer cells. Phytother Res 23: 6-13, 2009.
24. Ang-Lee MK, Moss J and Yuan CS: Herbal medicines and perioperative care. JAMA 286: 208-216, 2001.
25. Newton SM, Lau C, Gurcha SS, Besra GS and Wright CW: The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis. J Ethnopharmacol 79: 57-67, 2002.
26. Brahmachari G, Mondal S, Gangopadhyay A, Gorai D, Mukhopadhyay B, Sana S and Brahmachari AK: Swertia (Gentianaceae): chemical and pharmacological aspects. Chem Biodivers 1: 1627-1651, 2004.
27. Hartwell LH and Weinert TA: Checkpoints: controls that ensure the order of cell cycle events. Science 246: 629-634, 1989.
28. Shi P, Huang Z and Chen G: Rhein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma BEL-7402 cells. Am J Chin Med 36: 805-813, 2008.
29. Lim YJ, Rhee JC, Bae YM and Chun WJ: Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells. World J Gastroenterol 13: 1947-1952, 2007.
30. Hassan KA, El-Naggar AK, Soria JC, Liu D, Hong WK and Mao L: Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin Cancer Res 7: 2458-2462, 2001.